Pharmacists urge investment in laboratories to combat drug resistance
A Nigerian clinical pharmacist emphasizes the need for investment in laboratories and behavioral changes to combat antimicrobial resistance in healthcare.
Moshood Lawal, a clinical pharmacist in Nigeria and technical consultant for the Commonwealth Partnership for Antimicrobial Stewardship, has stressed the urgent need for investment in laboratories that are properly equipped to combat antimicrobial resistance (AMR). He highlighted the importance of having laboratories that can operate efficiently with reliable power supply, as this would enhance the overall response to AMR challenges within the healthcare system.
In addition to infrastructure improvements, Lawal pointed out the need for a significant shift in patient behavior. Many individuals are consuming antimicrobials without medical prescriptions, and there is often non-compliance with prescribed guidelines. This misuse leads to overuse of these important medications, which compounds the problem of antimicrobial resistance. He emphasized that public awareness and education are crucial in changing these harmful practices.
Antimicrobial resistance occurs when pathogens such as bacteria and viruses evolve to resist the effects of drugs, making infections more difficult to treat and increasing the risk of severe illness or death. This trend not only poses a significant threat to public health but also results in escalated healthcare costs due to prolonged illness and the need for more expensive treatments. Thus, Lawal's call for enhanced laboratory capabilities and changed prescribing behaviors aims to mitigate this growing public health crisis in Nigeria.